These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7881935)

  • 1. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
    Choy A; McCulloch PG
    Br J Surg; 1995 Jan; 82(1):135. PubMed ID: 7881935
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
    Bonnema J; van Geel AN; Wiggers T; Ligtenstein DA
    Br J Surg; 1994 Nov; 81(11):1693. PubMed ID: 7827911
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer.
    Oertli D; Laffer U; Haberthuer F; Kreuter U; Harder F
    Br J Surg; 1994 Jun; 81(6):856-9. PubMed ID: 8044602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tranexamic acid gel in patients treated with oral anticoagulants].
    Ripollés-de Ramón J; Muñoz-Corcuera M; Bravo-Llatas C; Bascones-Martínez A
    Med Clin (Barc); 2014 Dec; 143(11):484-8. PubMed ID: 24268907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid: a review of its use in surgery and other indications.
    Dunn CJ; Goa KL
    Drugs; 1999 Jun; 57(6):1005-32. PubMed ID: 10400410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
    Peña JJ; Mateo E; Martín E; Llagunes J; Carmona P; Blasco L;
    Rev Esp Anestesiol Reanim; 2013 Mar; 60(3):142-8. PubMed ID: 22795924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Epinephrine Plus Tranexamic Acid Reduces Early Postoperative Blood Loss and Inflammatory Response: A Randomized Controlled Trial.
    Zeng WN; Liu JL; Wang FY; Chen C; Zhou Q; Yang L
    J Bone Joint Surg Am; 2018 Feb; 100(4):295-304. PubMed ID: 29462033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid--an old drug still going strong and making a revival.
    Tengborn L; Blombäck M; Berntorp E
    Thromb Res; 2015 Feb; 135(2):231-42. PubMed ID: 25559460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    Myles PS; Smith JA; Forbes A; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; McGuinness S; Byrne K; Chan MT; Landoni G; Wallace S;
    N Engl J Med; 2017 Jan; 376(2):136-148. PubMed ID: 27774838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
    Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
    Patel J; Prajapati M; Patel H; Gandhi H; Deodhar S; Pandya H
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):118-122. PubMed ID: 28068786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncologic asepsis in the surgery of breast cancer].
    Vilanova DL; Montoreano F
    Prensa Med Argent; 1965 May; 52(16):1030-3. PubMed ID: 5844684
    [No Abstract]   [Full Text] [Related]  

  • 13. Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis.
    Adler Ma SC; Brindle W; Burton G; Gallacher S; Hong FC; Manelius I; Smith A; Ho W; Alston RP; Bhattacharya K
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):26-35. PubMed ID: 21115366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
    Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive measures against metastases and local recurrence in cancer surgery.
    McDonald GO
    Proc Natl Cancer Conf; 1970; 6():19-31. PubMed ID: 5458094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metastasis occurrence, prophylaxis and tumor management with enzymes from the viewpoint of the gynecologist].
    Stojanow G
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(5):355-63. PubMed ID: 5536491
    [No Abstract]   [Full Text] [Related]  

  • 17. Supportive topical tranexamic acid application for hemostasis in oral bleeding events - Retrospective cohort study of 542 patients.
    Zirk M; Zinser M; Buller J; Bilinsky V; Dreiseidler T; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):932-936. PubMed ID: 29627368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic Use in the Perioperative Setting: Aminocaproic Acid and Tranexamic Acid.
    Golembiewski J
    J Perianesth Nurs; 2015 Dec; 30(6):560-563. PubMed ID: 26596393
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study.
    Mebel D; Akagami R; Flexman AM
    Anesth Analg; 2016 Feb; 122(2):503-8. PubMed ID: 26554461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
    Kim YT; Kang MW; Lee JK; Lee YM; Kim JI
    BMC Musculoskelet Disord; 2018 Jul; 19(1):227. PubMed ID: 30021575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.